Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors
Green tea leaf extract (50% polyphenols) 200 mg
GLP-1s have quickly moved from the world of diabetes care into mainstream conversations about weight management, metabolic health, and now, reproductive health
Biorc pod uwag badania, ktre zostay przeprowadzone na zwierztach i potwierdziy przenikanie semalutydu do mleka, lek Ozempic nie powinien by stosowany w okresie karmienia piersi
We use them to support energy, focus, and metabolic function while the core of your program medication where indicated, nutrition, and body-composition tracking does the heavy lifting
At Modera Clinic & Med Spa, every peptide and injection therapy is administered under physician supervision and tailored to your individual health history and goals
